These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29276710)

  • 1. Use of Tachycardia in Patients With Submassive Pulmonary Emboli to Risk Stratify for Early Initiation of Thrombolytic Therapy: A Case Series Comparing Early Versus Late Thrombolytic Initiation.
    Cheta J; Long A; Marik P
    J Investig Med High Impact Case Rep; 2017; 5(4):2324709617744232. PubMed ID: 29276710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Controversies in Thrombolytic Use in Acute Pulmonary Embolism.
    Long B; Koyfman A
    J Emerg Med; 2016 Jul; 51(1):37-44. PubMed ID: 27071316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolytic therapy for acute pulmonary embolism: a critical appraisal.
    Todd JL; Tapson VF
    Chest; 2009 May; 135(5):1321-1329. PubMed ID: 19420199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis for acute pulmonary embolism.
    Piazza G; Goldhaber SZ
    Vasc Med; 2010 Oct; 15(5):419-28. PubMed ID: 20926501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of right ventricular myocardial strain in assessment of response to thrombolytic therapy in acute pulmonary embolism.
    Lo A; Stewart P; Younger JF; Atherton J; Prasad SB
    Eur J Echocardiogr; 2010 Dec; 11(10):892-5. PubMed ID: 20819837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of life-threatening pulmonary embolism.
    Marshall PS; Mathews KS; Siegel MD
    J Intensive Care Med; 2011; 26(5):275-94. PubMed ID: 21606060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk factor age in normotensive patients with pulmonary embolism: Effectiveness of age in predicting submassive pulmonary embolism, cardiac injury, right ventricular dysfunction and elevated systolic pulmonary artery pressure in normotensive pulmonary embolism patients.
    Keller K; Beule J; Coldewey M; Geyer M; Balzer JO; Dippold W
    Exp Gerontol; 2015 Sep; 69():116-21. PubMed ID: 25981740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-dimer for risk stratification in haemodynamically stable patients with acute pulmonary embolism.
    Keller K; Beule J; Schulz A; Coldewey M; Dippold W; Balzer JO
    Adv Med Sci; 2015 Sep; 60(2):204-10. PubMed ID: 25847178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic therapy for submassive pulmonary embolism.
    Lankeit M; Konstantinides S
    Best Pract Res Clin Haematol; 2012 Sep; 25(3):379-89. PubMed ID: 22959553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Submassive Pulmonary Embolism: A Re-evaluation of Hemodynamic Instability.
    Obi M; Packer CD
    Cureus; 2019 May; 11(5):e4644. PubMed ID: 31312570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis is not warranted in submassive pulmonary embolism: a systematic review and meta-analysis.
    Ramakrishnan N
    Crit Care Resusc; 2007 Dec; 9(4):357-63. PubMed ID: 18052901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta-analysis.
    Nakamura S; Takano H; Kubota Y; Asai K; Shimizu W
    J Thromb Haemost; 2014 Jul; 12(7):1086-95. PubMed ID: 24829097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial.
    Steering Committee
    Am Heart J; 2012 Jan; 163(1):33-38.e1. PubMed ID: 22172434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Thrombolysis for Pulmonary Embolism: Who and How.
    Tapson VF; Friedman O
    Tech Vasc Interv Radiol; 2017 Sep; 20(3):162-174. PubMed ID: 29029710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Thrombolytic Therapy for Patients with a Submassive Pulmonary Embolism.
    Murphy E; Lababidi A; Reddy R; Mendha T; Lebowitz D
    Cureus; 2018 Jun; 10(6):e2814. PubMed ID: 30397555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound Accelerated Thrombolysis May Be an Effective and Safe Treatment Modality for Intermediate Risk/Submassive Pulmonary Embolism.
    Ozmen C; Deniz A; Akilli RE; Deveci OS; Cagliyan CE; Aktas H; Celik Aİ; Akpinar AA; Disel NR; Balli HT; Hanta İ; Demir M; Usal A; Kanadasi M
    Int Heart J; 2016; 57(1):91-5. PubMed ID: 26673444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Submassive pulmonary embolism.
    Busse LW; Vourlekis JS
    Crit Care Clin; 2014 Jul; 30(3):447-73. PubMed ID: 24996605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Massive pulmonary embolism: what level of aggression?
    Konstantinides SV
    Semin Respir Crit Care Med; 2008 Feb; 29(1):47-55. PubMed ID: 18302086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based emergency medicine/critically appraised topic. Thrombolytic therapy for submassive pulmonary embolism?
    Worster A; Smith C; Silver S; Brown MD
    Ann Emerg Med; 2007 Jul; 50(1):78-84. PubMed ID: 17449142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound-accelerated catheter-directed thrombolysis for acute submassive pulmonary embolism.
    Bagla S; Smirniotopoulos JB; van Breda A; Sheridan MJ; Sterling KM
    J Vasc Interv Radiol; 2015 Jul; 26(7):1001-6. PubMed ID: 25704224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.